Skip to main content

Peer Review reports

From: Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome

Original Submission
13 Mar 2020 Submitted Original manuscript
26 Mar 2020 Reviewed Reviewer Report - Renato Bocchini
4 Apr 2020 Reviewed Reviewer Report - Carmelo Scarpignato
8 May 2020 Author responded Author comments - Xiaojun Zhuang
14 May 2020 Author responded Author comments - Xiaojun Zhuang
Resubmission - Version 2
8 May 2020 Submitted Manuscript version 2
Publishing
5 Jun 2020 Editorially accepted
12 Jun 2020 Article published 10.1186/s12876-020-01336-6

You can find further information about peer review here.

Back to article page